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Abstract
Background: Studies using laboratory animals under what are considered to be “standard” conditions normally
offer unrestricted amounts of food to the animals, which can lead to metabolic disorders. Moreover, standard diets
have different compositions.
Aim: Therefore, the aim of the present study was to assess the effects of two non-isocaloric diets (commercial
Purina® and AIN-93M), which are considered standard diets, on the accumulation of fat in the liver of rats when
offered ad libitum or in a restricted amount.
Methods: Thus, 40 Wistar rats (90 days old) were separated into 4 groups according to the amount of food
offered (ad libitum or dietary restriction) and the type of diet (commercial diet, 3,028.0 kcal/g or AIN-93M, 3,802.7
kcal/g): animals fed the commercial Purina® diet ad libitum (AP), animals fed restricted amounts of the commercial
Purina® diet (RP), animals fed the AIN-93M diet ad libitum (AD), and animals fed restricted amounts of the AIN-93M
diet (RD). Dietary restriction consisted of pair-feeding the RP and RD groups with 60% of the total food consumed
by the corresponding ad libitum groups.
Results: Because of its higher carbohydrate and calorie content, AIN-93M was found to accelerate weight gain,
reduce glucose tolerance and peripheral insulin sensitivity, and increase the amount of fat in the liver when
compared to the commercial diet. Conversely, a 40% dietary restriction assisted in weight loss without causing
malnutrition, contributing to an improved glucose tolerance and higher levels of HDL cholesterol.
Conclusion: Therefore, differences in the amount of carbohydrates and calories provided by the diet can lead to
important metabolic disorders, such as impaired tolerance and accumulation of hepatic fat, and dietary restriction
improves serum and tissue lipid profiles in laboratory animals.
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Background
Non-alcoholic fatty liver disease (NAFLD) is charac-
terised by the presence of fat droplets in the liver [1,2].
Lipid levels equal to or greater than 5% of an organ’s
weight [1,3] characterises steatosis, which may range
from simple fat accumulation without any evidence of
inflammation to necroinflammatory manifestations,
including steatohepatitis. Steatohepatitis, in turn, may
progress to fibrosis in 50% of cases, to cirrhosis in 15%
of cases, and to liver failure in 3% of cases [4-8].
Hepatic fat accumulation can be found in 57.5 to 75%
of obesity cases [6] due to alterations such as an
increase in fat consumption, a decrease in oxidation,
and lipid secretion by the liver [9] or other mechanisms
such as oxidative stress, the organism’s inflammatory
response, and insulin resistance (IR) [10,11]. Increased
carbohydrate consumption may lead to IR [12], where
peripheral tissues show an abnormal response to insulin
that may lead to glucose intolerance [13] and, conse-
quently, to NAFLD [14-17].
The key for reducing the disorders that stem from
insulin resistance, glucose intolerance, and NAFLD is a
change in lifestyle, including regular participation in
physical activity and caloric restriction [18-21].
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Given the limitations of research involving humans,
animal models, in particular rodents, have become
important research tools for several areas of science.
Two types of “standard diets”, a commercial diet for
rodents (Purina®) and a diet proposed by the American
Institute of Nutrition (AIN), AIN-93 [22], are often used
in physiological research studies that use rodents as
experimental models. The problem with labelling these
two diets as standard diets is the difference in their caloric
values, which is approximately 800 kcal/g (Purina®:
3,028.0 kcal/kg and AIN-93M: 3,802.7 kcal/kg). This dis-
crepancy is mainly due to differences in the amount of
sugar present in each diet (Purina: 437 g/kg and AIN-
93M: 700 g/kg). As previously noted, a high carbohydrate
intake contributes to the development of metabolic disor-
ders and may induce NAFLD. Therefore, the aim of the
present study was to assess the effects of two non-isocalo-
ric diets considered to be standard (commercial Purina®
and AIN-93M) for studies involving rodents as experimen-
tal models, offered ad libitum or in restricted amounts on
the development of non-alcoholic fatty liver disease in rats.
Results
Animals fed ad libitum had higher weights than animals
subjected to dietary restriction. When comparing both
ad libitum groups, the group of animals fed the AIN-
93M diet (AD group) was shown to have a larger weight
gain (Figure 1).
Food intake was lower in the AD group when com-
pared to the AP group (Figure 2A). Regarding caloric
intake, the amount of calories ingested by the groups
subjected to dietary restriction was smaller than that of
the ad libitum groups, as was expected (Figure 2B). The
AIN-93M diet was shown to have a higher food effi-
ciency than the commercial diet (Figure 2C).
Groups subjected to the dietary restriction presented a
smaller area under the glucose curve during the oral
glucose tolerance test (OGTT) (Figure 3A). However,
when analysing the insulin tolerance test (ITT), no sig-
nificant differences could be observed between the
groups (Figure 3B).
Regarding the amount of triglycerides contained in the
subcutaneous (Figure 4A) and retroperitoneal (Figure
4B) adipose tissues, the AD group was found to have a
higher triglyceride concentration when compared to the
other groups. As for the mesenteric adipose tissue (Fig-
ure 4C), it was possible to observe a decrease in the tri-
glyceride content in the groups subjected to dietary
restriction.
The AD group presented higher concentrations of
total hepatic fat when compared to the dietary restric-
tion groups, and a tendency for an increase was noted
when compared to the AP group (p = 0.067) (Figure 5).
Figure 1 Area under the curve for body weights from the
whole experimental procedure. AP = ad libitum pellet, RP =
dietary restriction pellet, AD = ad libitum diet, and RD = dietary
restriction diet. *≠ AP and AD and **≠ AP, RP, and RD (10 animals/
group).
Figure 2 Food intake (A), caloric intake (B), and food efficiency
(C) during the whole experimental procedure. AP = ad libitum
pellet, RP = dietary restriction pellet, AD = ad libitum diet, and RD =
dietary restriction diet. *≠ AP and AD and **≠ AP, RP, and RD (10
animals/group).
Figure 3 Area under the glycaemic curve during glucose
tolerance test (A) and % glucose removal during the insulin
tolerance test (B) performed at the end of the experiment. AP
= ad libitum pellet, RP = dietary restriction pellet, AD = ad libitum
diet, and RD = dietary restriction diet. *≠ AP, RP, and RD (10
animals/group).
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Regarding the serum biochemistry, a greater concen-
tration of HDL cholesterol could be observed in the
groups subjected to the dietary restriction. No signifi-
cant differences in LDL cholesterol, total cholesterol, tri-
glycerides, glucose, total serum protein, and serum
albumin levels could be observed among the studied
groups (Table 1).
Discussion
Because there appears to be little concern with respect
to the best way to feed animals used as “controls” in
many scientific studies involving animal models, the
present study aimed to assess the metabolic effects of
dietary restriction in rats associated with the administra-
tion of two non-isocaloric diets (commercial Purina®
diet and semi-purified AIN-93M diet) that are consid-
ered standard diets for rodents. The main results of this
study demonstrate that a 40% dietary restriction reduced
weight gain without causing malnutrition, improved glu-
cose tolerance, and increased the levels of circulating
HDL cholesterol. The AIN-93M diet increased weight
gain, reduced glucose tolerance, and led to the accumu-
lation of fat in the liver when compared to the commer-
cial diet due to its higher caloric and carbohydrate
contents.
Serum albumin and total serum proteins were deter-
mined to assess the animals’ nutritional statuses [23-25].
According to these results, animals subjected to the
dietary restriction described in this study did not pre-
sent malnutrition, given that no alterations in serum
albumin and total serum proteins could be observed in
any of the animals.
Regarding the serum lipid profile, increased levels of
HDL cholesterol could be observed in the groups sub-
jected to dietary restriction, demonstrating that a 40%
dietary restriction does not cause malnutrition; this find-
ing is in accordance with other studies [21-26], which
also showed improvements in the lipid profiles of the
animals.
In the present study, animals belonging to the ad libi-
tum groups showed a larger weight gain when compared
to animals in the groups subjected to dietary restriction.
Animals fed the AIN-93M diet, which contains greater
amounts of carbohydrates (26.3%) and calories (800
kcal/g of diet) [22] than the commercial diet, gained
more weight when compared to those maintained with
Figure 4 Triglyceride concentrations of different adipose tissue
depots, subcutaneous (A), retroperitoneal (B), and mesenteric
(C), at the end of the experiment. AP = ad libitum pellet, RP =
dietary restriction pellet, AD = ad libitum diet, and RD = dietary
restriction diet. *≠ AP and AD, ***≠ AP, RP, and RD (10 animals/
group).
Figure 5 Total hepatic fat concentrations at the end of the
experiment. AP = ad libitum pellet, RP = dietary restriction pellet,
AD = ad libitum diet, and RD = dietary restriction diet. (10 animals/
group).
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the commercial diet, when allowed to feed ad libitum.
However, when subjected to dietary restriction, the
effect of the diet on weight gain was inhibited.
The accumulation of body fat resulting from increased
carbohydrate intake occurs due to the fact that excess
carbohydrates, when not used by the organism, are initi-
ally degraded into pyruvate and then attached to coen-
zyme A (CoA) to become acetyl-CoA. Acetyl-CoA is
transformed into malonyl-CoA with the help of the
enzyme acetyl-CoA carboxylase. The fatty acid synthase
enzyme then converts malonyl-CoA into palmitate. Fol-
lowing the esterification of palmitate with the a-glycerol
phosphate in adipose tissue, triacylglycerol is formed
and stored as an energy reserve [28].
The effects of both diets on the accumulation of body
fat are more pronounced when analysing the total trigly-
ceride concentrations of the three main fat depots in the
organism (mesenteric, subcutaneous, and retroperito-
neal). The effect of the high-calorie diet, AIN-93M, on
stimulating the accumulation of fat when compared to
the commercial diet became evident, as did the effect of
dietary restriction in modulating such an accumulation.
Regarding the analysis of food consumption in the ad
libitum groups, the AD group ingested smaller amounts
of food than did the AP group. These data are in accor-
dance with other studies [29], where rats fed high-cal-
orie diets presented a lower food intake. However, no
significant difference regarding caloric intake could be
observed among the studied groups.
When considering food efficiency, meaning the ani-
mal’s ability to transform ingested calories into body
weight [30,31], animals belonging to the groups sub-
jected to dietary restriction showed negative values,
which were considered beneficial given that the aim of
dietary restriction was to minimise weight gain. When
comparing ad libitum groups, the animals that were fed
the AIN-93M diet (AD) were more efficient in trans-
forming ingested energy into body mass.
It is known that the accumulation of adipose tissue
can lead to insulin resistance, given that the adipose
tissue is an endocrine organ that secretes several pro-
inflammatory substances that may interfere in the hor-
mone’s signalling pathway and lead to a resistance to
its actions [32-34]. The present study showed that the
greater weight gain observed in the ad libitum groups
compared to the groups subjected to dietary restriction
was not sufficient to cause insulin resistance. This may
be because these rats were not obese and showed a
normal weight gain for their age [35]. Conversely,
when assessing glucose tolerance, impairments deriving
from the administration of the AIN-93M diet were
identified.
The OGTT showed that rats fed the AIN-93M diet ad
libitum had a lower glucose tolerance when compared
to those fed the commercial diet. According to [36,17],
the chronic administration of a carbohydrate-rich diet
may lead to glucose intolerance. Given this substrate’s
high availability, if it is not used by the organism, its
transformation into fat may cause an increase in the
availability of circulating free fatty acids and an increase
in adipose tissue, as was observed in the present study.
This may lead to a malfunction of the insulin-signalling
pathway [37]. A tendency for a reduction in peripheral
sensitivity to the hormone could be observed in the AD
group (p = 0.064) when compared to the AP group. If
the experimental period had been extended, insulin
resistance may have been observed in this group, which
would explain the glucose intolerance.
Non-alcoholic fatty liver disease (NAFLD) is charac-
terised by the accumulation of fat in the liver, which
may lead to inflammation, fibrosis, and organ failure
[4-8]. There is no specific treatment for this disease to
date. Therefore, it is clear that research involving labora-
tory animals is of great importance to increasing knowl-
edge about this disease [38].
It is known that hepatic lipogenesis is activated follow-
ing the consumption of carbohydrates because the
resulting increase in insulin secretion activates the lipo-
genic transcription factor, SREBP-1c [39,40]. In indivi-
duals with insulin resistance, the situation is aggravated
by increased circulating insulin levels, which stimulate
the synthesis of triglycerides and increases the secretion
Table 1 Serum data obtained at the end of the experimental period
AP RP AD RD
HDL (mg/dL) 32.65 ± 3.07 38.35 ± 4.44* 31.50 ± 4.22 41.62 ± 3.91*
LDL (mg/dL) 36.43 ± 7.08 51.38 ± 8.11 42.96 ± 12.57 52.31 ± 7.76
TG (mg/dL) 101 ± 31.54 105.85 ± 27.02 96.64 ± 20.2 89.31 ± 28.75
Total Cholesterol (mg/dL) 65.56 ± 10.29 74.69 ± 11.79 62.44 ± 18.27 76.03 ± 11.28
Glucose (mg/dL) 82.97 ± 10.53 91.27 ± 23.21 90.17 ± 16.28 106.95 ± 15.86
Total Protein (g/dL) 6.79 ± 0.51 6.79 ± 0.16 6.85 ± 0.3 6.97 ± 0.26
Albumin (g/dL) 2.80 ± 0.39 2.75 ± 0.09 2.90 ± 0.15 2.91 ± 0.13
Data are expressed as mean ± standard deviation.
AP = ad libitum purina; RP = dietary restriction purina; AD = ad libitum diet, and RD = dietary restriction diet. *≠ AP and AD (10 animals/group).
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of VLDL cholesterol, contributing to a greater accumu-
lation of fat in the liver [12].
No significant differences in the accumulation of
hepatic fat were observed in the present study, though a
strong statistic tendency could be noted (p = 0.067). If
the experiment was extended, it may have shown that
the AIN-93M diet would most likely lead to insulin
resistance and, consequently, a greater accumulation of
fat in the liver due to its high carbohydrate content
when compared to the commercial Purina® diet [12].
Conclusion
The present study illustrates that differences in the
amounts of carbohydrates and calories provided in a
diet may lead to important metabolic changes, such as
impaired tolerance and accumulation of hepatic fat, and
that dietary restriction improves serum and tissue lipid
profiles in laboratory animals.
Materials and method
Animal treatment
Forty Wistar rats, which were 90 days old at the begin-
ning of the study, were housed in polyethylene cages
measuring 37 × 31 × 16 cm (five rats per cage), at room
temperature (25°C) with a 12-hour light/dark photoper-
iod. All procedures performed on the animals were sub-
mitted to and approved by the Animal Research Ethics
Committee (CEUA) of the Institute of Biosciences at
UNESP, Rio Claro campus (Process number: 2011/
6274).
Experimental design and groups
The animals were separated, according to the dietary
protocol, into four groups (10 per group): animals fed
the commercial Purina® diet ad libitum (AP), animals
fed restricted amounts of the commercial Purina® diet
(RP), animals fed the AIN-93M diet ad libitum (AD),
and animals fed restricted amounts of the AIN-93M
diet (RD).
The daily food consumption of the AP and AD ani-
mals was recorded. The following day, animals in the
dietary restriction groups were pair-fed an amount
equivalent to 60% of the previous day’s average intake of
the respective ad libitum group. This protocol was cho-
sen because it provides dietary restriction without caus-
ing malnutrition and increases the animal’s quality of
life [41-45]. All animals were offered free access to
water, regardless of their group.
Diet Compositions
Commercial Purina® Diet (Paulínia/SP, Brazil): This
diet was composed of 43.7% carbohydrates, 23% protein,
and 4% fat at 3,028 kcal/g. The remainder of the ingre-
dients were comprised of minerals, fibre, and vitamins.
AIN-93M (Semi-purified diet, according to the Ameri-
can Institute of Nutrition, AIN-93M [22]): The diet was
composed of 70% carbohydrates, 14% protein, and 4%
fat at 3,802.7 kcal/g. The remainder of the ingredients
were comprised of minerals, fibre, and vitamins.
Oral Glucose Tolerance Test - OGTT
An oral glucose tolerance test (OGTT) was performed
on the animals at the end of the experiment after a 12-
hour fast. An initial blood sample was obtained through
a small cut at the end of the animal’s tail. A glucose
solution (80%) was then administered to each animal in
the amount of 2 g/kg of body weight using a polyethy-
lene gastric tube. Blood samples were collected 30, 60,
and 120 minutes later using heparinised capillaries cali-
brated to 25 μL for determining glucose concentrations.
A single cut at the end of the tail was sufficient for all
sample collections. Blood glucose concentrations were
determined by the glucose oxidase method using com-
mercial kits (Laborlab®). Results were analysed by calcu-
lating the area under the glucose curve using the
trapezoidal method [46] with the help of the Origin 6.0
software (2000).
Insulin Tolerance Test - ITT
Insulin sensitivity was evaluated through the insulin tol-
erance test (ITT). The ITT was performed at the end of
the experiment and 48 hours after the OGTT. An initial
blood sample was obtained by making a cut at the end
of the animal’s tail (time 0). An insulin solution, at the
dose of 150 mU/100 g body weight, was then adminis-
tered through an intraperitoneal injection. New blood
samples were obtained after 4, 8, 12, 16, and 20 minutes
using heparinised capillaries calibrated to 25 μL for
determining the glucose concentrations by using com-
mercial kits (Laborlab®). A single cut at the end of the
tail was sufficient for all sample collections. The results
obtained were analysed by calculating the glucose
removal rate (KITT). KITT was expressed as %/minute
and was calculated using the formula (0.0693/t1/2) ×
100. Glucose removal (t1/2) was calculated by a least
squares analysis of the curve of the blood glucose levels
during the period of insulin decay following its adminis-
tration [47], using the Origin 6.0 software.
Evaluation of the nutritional state
Body mass and food intake were recorded daily through-
out the experimental period. The results were analysed
by calculating the areas under the curves for body mass
and food intake throughout the experiment using the
trapezoidal method [48]. Food efficiency was calculated
to evaluate the animal’s ability to convert consumed
food energy into body weight. This calculation was
made according to the World Health Organization [30],
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by dividing the average weekly weight gain of animals
within each box (g) by the total energy intake (kcal).
The energy intake was calculated by multiplying the
amount of food ingested by the caloric value of each
diet.
At the end of the experiment, all animals were anaes-
thetised with CO2 prior to being euthanised by decapita-
tion. Blood samples were collected for the determination
of blood glucose, triglycerides, total cholesterol, LDL
cholesterol and HDL cholesterol levels by using com-
mercial kits (Laborlab®, São Paulo/Brazil) and for total
serum protein and serum albumin measurements. Sam-
ples for determining total lipids were also collected from
the liver and from different depots of adipose tissue
(mesentery, subcutaneous, and retroperitoneal) for tri-
glyceride analysis [49].
Statistics
The normality of the data was confirmed by the Sha-
piro-Wilk test. The results are presented as mean ±
standard deviation. Comparisons between groups were
made through an analysis of variance (one-way
ANOVA) and the Newman-Keuls post-hoc test when
necessary. A predetermined 5% significance level was
used for all the analyses. The statistical programme used
was the SPSS 17.0.
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